Regulation of Myofilament Contractile Function in Human Donor and Failing Hearts

Kerry S McDonald1, Laurin M Hanft1, Joel C Robinett1

  • 1Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, MO, United States.

Insights

Heart failure (HF) impairs cardiac function by altering myofibrillar mechanics. In failing hearts, diminished length-dependent regulation of myofilament function contributes to reduced ventricular performance, highlighting a key mechanism in contractile dysfunction.

Area of Science:

  • Cardiovascular Physiology
  • Myocardial Contractility
  • Heart Failure Pathophysiology

Background:

  • Heart failure (HF) is characterized by impaired myocardial contractile function.
  • Understanding the myofibrillar basis of this dysfunction is crucial for developing targeted therapies.
  • Previous studies suggest tissue remodeling contributes to force decline in multicellular HF preparations.

Purpose of the Study:

  • To investigate the myofibrillar basis of contractile dysfunction in failing human myocardium.
  • To elucidate the role of myofilament calcium (Ca2+) and sarcomere length (SL) dependence in HF.
  • To compare contractile properties of cardiac myocytes from donor and failing human hearts.

Main Methods:

  • Isolation and permeabilization of cardiac myocytes from human donor and HF left ventricular biopsies.
  • Measurement of Ca2+ and SL dependence of force, loaded shortening, and power output using a force transducer and position motor.
  • Analysis of peak power output normalized to isometric force (PNPO) under varying Ca2+ and SL conditions.

Main Results:

  • Maximal Ca2+-activated isometric force and maximal force development rates were similar between donor and HF myocytes.
  • Peak power output normalized to isometric force (PNPO) decreased with reduced Ca2+ activation in both groups.
  • The sarcomere length (SL) dependence of PNPO was significantly diminished in failing human myocytes compared to donor myocytes.

Conclusions:

  • Contractile dysfunction in failing human myocardium is not due to reduced maximal force or cross-bridge cycling rates at the myocyte level.
  • Altered length-dependent regulation of myofilament function, specifically a blunted response of power output to changes in SL, impairs ventricular performance in HF.
  • These findings highlight a critical role for altered myofilament calcium sensitivity and length-dependent mechanisms in the pathophysiology of human heart failure.

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.3K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
319
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.5K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
575
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.1K